CheckImmune GmbH
About us
CheckImmune is a spin-off company of Charité Universitätsmedizin Berlin with strong links to academic state-of-the art research. CheckImmune is providing biomarker studies with focus on novel immunotherapeutics (small molecules, biologics, Advanced Therapy Medicinal Products – ATMPs) and immunological challenges in other medical areas. CheckImmune is accredited according to ISO 17025 and 15189 and fulfills the requirements of GCLP (Good Clinical Laboratory Practice).
We are a team of well recognized experts for biomarker analyses and data interpretation.
Our Services are Selection/validation of drug lead candidates, Phase 0 studies, Therapy monitoring (safety, efficacy/stratification) and Data analysis and scientific & medical interpretation. At CheckImmune, we develop highly specialized immunological biomarker assays and provide end-to-end lab services for clinical and preclinical trials. From assay design to regulatory-grade data analysis – we help biopharma companies understand immune responses with precision.
We are a certified service provider for 10x Genomics, OLINK and bio-techne.
Address
Robert-Rössle-Str. 10
13125 Berlin
Germany
E-mail: enquiries@checkimmune.com
Phone: +49 30 94893700
Internet: checkimmune.com
Contact person:
Products & Services
Our Technology platforms are
- Complex Flow & Spectral Cytometry
- Molecular & Multi-Omics Analysis: Bulk RNAseq, TCR /BCR repertoire, Single cell Multiomics (RNAseq, TCRseq, CITEseq) Spatial multi-omics, qRT- PCR (e.g. IFN signature) and digitalPCR
- Multiplex Ligand Assays (MSD, Ella, OLINK)
- Functional Assays
- Anti-Drug Response (ADA/ADT)